Compare KALV & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALV | NBN |
|---|---|---|
| Founded | N/A | 1872 |
| Country | United States | United States |
| Employees | N/A | 234 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 933.4M |
| IPO Year | 2014 | N/A |
| Metric | KALV | NBN |
|---|---|---|
| Price | $19.95 | $124.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $32.60 | ★ $117.50 |
| AVG Volume (30 Days) | ★ 1.1M | 103.5K |
| Earning Date | 05-09-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $50,000,000.00 | N/A |
| Revenue This Year | $187.19 | $13.77 |
| Revenue Next Year | $54.93 | $18.72 |
| P/E Ratio | ★ N/A | $11.29 |
| Revenue Growth | ★ 495.66 | N/A |
| 52 Week Low | $9.83 | $79.05 |
| 52 Week High | $21.31 | $126.26 |
| Indicator | KALV | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 76.54 |
| Support Level | $14.66 | $104.40 |
| Resistance Level | $21.31 | $126.26 |
| Average True Range (ATR) | 1.35 | 3.42 |
| MACD | 0.14 | 1.75 |
| Stochastic Oscillator | 75.14 | 99.79 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.